The impact of rufloxacin given as prophylaxis to patients with cancer on their oral and faecal microflora

Journal of Antimicrobial Chemotherapy

Volumn 38, Issue 5, 1996, Pages 839-847

  D'Antonio, D ^a   Pizzigallo, E ^a   Iacone, A ^a   Violante, B ^a   Di Marzio, A ^a   Lombardo, M ^a   Fioritoni, G ^a   Staniscia, T ^a   Romano, F ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; RUFLOXACIN;

ADULT; AGED; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEROIDES; CANCER; CLINICAL TRIAL; COAGULASE NEGATIVE STAPHYLOCOCCUS; DRUG EFFICACY; ENTEROBACTERIACEAE; ENTEROCOCCUS; FECES MICROFLORA; FEMALE; GASTROINTESTINAL SYMPTOM; GRAM NEGATIVE BACTERIUM; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MORAXELLA CATARRHALIS; MOUTH FLORA; ORAL DRUG ADMINISTRATION; RASH;

EID: 0029806157     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/38.5.839     Document Type: Article

References (19)

1. Cocuzza, G. & William, R. J. (1991). The antibacterial activity of rufloxacin. Journal of Chemotherapy, Suppl 4, 72-3.
2. Cometta, A., Calandra, T., Bille, J. & Glauser, M. P. (1994). Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia. New England Journal of Medicine 330, 1240-1.
3. D'Antonio, D., Piccolomini, R., Iacone, A., Fioritoni, G., Parruti, G., Betti, S. et al. (1994). Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies. Journal of Antimicrobial Chemotherapy 33, 837-44.
4. Dekker, A. W., Rosenberg-Arska, M. & Verhoef, J. (1987). Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin. Annals of Internal Medicine 106, 7-12.
5. Donnelly, J. P. (1993a). Selective decontamination of the digestive tract and its role in antimicrobial prophylaxis. Journal of Antimicrobial Chemotherapy 31, 813-29.
6. Donnelly, J. P. (1993b) Viridans Streptococci and Allogeneic Bone Marrow Transplant Recipients. PhD Thesis.
7. Donnelly, J. P. (1995). Bacterial complications of transplantation: diagnosis and treatment. Journal of Antimicrobial Chemotherapy 36, Suppl B, 59-72.
8. Donnelly, J. P., Masschmeyer, G. & Daenen, S. (On behalf of the EORTC Gnotobiotic Project Group). (1992). Selective oral antimicrobial prophylaxis for the prevention of infection in acute leukemia - ciprofloxacin versus co-trimoxazole plus colistin. European Journal of Cancer 28, 873-8.
9. Edlund, C., Kager, L., Malmborg, A. S., Sjostedt, S. & Nord, C. E. (1988). Effect of ofloxacin on oral and gastrointestinal microflora in patients undergoing gastric surgery. European Journal of Clinical Microbiology and Infectious Diseases 7, 135-43.
10. European Study Group on Antibiotic Breakpoints (1993). Breakpoint determination: rufloxacin. European Journal of Clinical Microbiology and Infectious Diseases 12, 574-5.
11. Finegold, S. M. & Baron, E. J. (1986). Bailey and Scott's Diagnostic Microbiology, 7th edn, Mosby St. Louis, MO.
12. GIMEMA (1991). Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. Annals of Internal Medicine 115, 7-12.
13. Imbimbo, B. P., Broccali, G. P., Cesana, M., Crema, F. & Parrinello Attardo, G. (1991). Inter-and intrasubject variabilities in the pharmacokinetics of rufloxacin after single oral administration to healthy volunteers. Antimicrobial Agents and Chemotherapy 35, 390-3.
14. Jansen, J., Cromer, M., Akard, L., Black, J. R., Wheat, L. J. & Allen, S. D. (1994). Infection prevention in severely mylosuppressed patients: a comparison between ciprofloxacin and a regimen selective antibiotic modulation of the intestinal flora. American Journal of Medicine 96, 335-41.
15. Kern, W. V., Andriof, E., Oethinger, M., Kern, P., Hacker, J. & Marre, R. (1994). Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center. Antimicrobial Agents and Chemotherapy 38, 681-7.
16. Marco F., Gimenez M. J., Jimenez-de-Anta, M. T., Marcos M. A., Salva P. & Aguilar L. (1995). Comparison of rufloxacin and norfloxacin effects of faecal flora. Journal of Antimicrobial Chemotherapy 35, 895-901.
17. Mattina, R., Cocuzza, C. E., Cesana, M. & Bonfiglio, G. (1991). In vitro activity of a new quinolone, rufloxacin, against nosocomial isolates. Chemotherapy 37, 260-9.
18. National Committee for Clinical Laboratory Standards (1990). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - 2nd edn: Approved Standard M7-A2. NCCLS, Villanova, PA.
19. Ravizzola, G., Pinsi, G., Cesana, M., De Rango, C., Peroni, L. & Turano, A. (1992). Antibacterial activity of rufloxacin in the Staphylococcus aureus rat granuloma pouch model. Current Microbiology 24, 349-53.